Summary Samples from 260 non-jaundiced patients with elevated plasma alkaline phosphatase activities were analysed for γ-glutamyltransferase and 5′-nucleotidase activity, and for alkaline phosphatase isoenzyme pattern. The plasma γ-glutamyltransferase activity was found to be a more sensitive index than that of plasma 5′-nucleotidase in confirming the presence of a liver component of the elevated plasma alkaline phosphatase. If the γ-glutamyltransferase level is normal it is probable that the increase in plasma alkaline phosphatase activity is of bone origin. However, an elevated γ-glutamyltransferase result does not exclude a bone component; in this situation plasma alkaline phosphatase isoenzymes should be estimated. The causes of elevated activities of plasma alkaline phosphatase, 5′-nucleotidase and γ-glutamyltransferase, found in this investigation were generally the same as those found by other workers. The effect of treatment by drugs on γ-glutamyltransferase, an inducible enzyme, needs more investigation.
References
1.
AronsenK. F.HansonA.NosslinB. (1965). The value of γ-glutamyl transpeptidase in differentiating viral hepatitis from obstructive jaundice. A statistical comparison with alkaline phosphatase. Acta chirurgica Scandinavica, 130, 92–99.
2.
BelfieldA.GoldbergD. M. (1969). Application of a continuous spectrophotometric assay for 5′ nucleotidase activity in normal subjects and patients with liver and bone disease. Clinical Chemistry, 15, 931–939.
3.
BooneD. J.RouthJ. I.SchrantzR. (1974). γ-glutamyl transpeptidase and 5′-nucleotidase. Comparison as diagnostics for hepatic disease. American Journal of Clinical Pathology, 61, 321–327.
4.
GreenwoodR. H.PruntyF. T. G.SilverJ. (1973). Osteomalacia after prolonged glutethimide administration. British Medical Journal, 1, 643–645.
5.
KindP. R. N.KingE. J. (1954). Estimation of plasma photophatase by determination of hydrolysed phenol with amino-antipyrine. Journal of Clinical Pathology, 7, 322–326.
6.
LumG.GambinoS. R. (1972). Serum gamma-glutamyl transpeptidase activity as an indictor of disease of the liver, pancreas, or bone. Clinical Chemistry, 18, 358–362.
7.
OrlowskiM. (1963). The role of γ-glutamyl transpeptidase in the internal diseases clinic. Archivum Immunologiae et Therapiae Experimentalis (Warszawa), 11, 1–61.
8.
PersijnJ. P.van der SlikW.KramerK.de RuijterC. A. (1968). A new method for the determination of serum nucleotidase. Zeitschrift für klinische Chemie und klinische Biochemie, 6, 441–446.
9.
RosalkiS. B. (1975). Gamma-glutamyl transpeptidase. Advances in Clinical Chemistry, 17, 53–107.
RosalkiS. B.RauD.LehmannD.PrenticeM. (1970). Determination of serum y-glutamyl transpeptidase activity and its clinical applications. Annals of Clinical Biochemistry, 7, 143–147.
